14 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 30056191 | Simvastatin attenuates the aberrant expression of angiogenic factors induced by glucose variability. | 2018 Sep | 1 |
2 | 30233664 | Effect of simvastatin on expression of VEGF and TGF-β1 in atherosclerotic animal model of type 2 diabetes mellitus. | 2018 Oct | 3 |
3 | 29201188 | Simvastatin augments activation of liver regeneration through attenuating transforming growth factor-β1 induced-apoptosis in obstructive jaundice rats. | 2017 Nov | 6 |
4 | 27121011 | Simvastatin ameliorates ventricular remodeling via the TGF‑β1 signaling pathway in rats following myocardial infarction. | 2016 Jun | 2 |
5 | 27478339 | Simvastatin Reduces Capsular Fibrosis around Silicone Implants. | 2016 Aug | 1 |
6 | 24083846 | The effect of simvastatin and erythropoietin on renal fibrosis in rats with unilateral ureteral obstruction. | 2014 Mar | 1 |
7 | 22890678 | Statin-induced T-lymphocyte modulation and neuroprotection following experimental subarachnoid hemorrhage. | 2013 | 1 |
8 | 21952298 | Effect of simvastatin on expression of transforming growth factor-β and collagen type IV in rat mesangial cells. | 2011 | 5 |
9 | 20024970 | Molecular and tissue responses in the healing of rat calvarial defects after local application of simvastatin combined with alpha tricalcium phosphate. | 2010 Apr | 2 |
10 | 20687301 | The effect of simvastatin on mRNA expression of transforming growth factor-beta1, bone morphogenetic protein-2 and vascular endothelial growth factor in tooth extraction socket. | 2009 Jun | 3 |
11 | 18791746 | Simvastatin ameliorates glomerulosclerosis in Adriamycin-induced-nephropathy rats. | 2008 Dec | 3 |
12 | 15855201 | Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction. | 2005 Aug | 1 |
13 | 16320597 | [Effects of simvastatin on TGF-beta system of diabetic rat kidneys]. | 2005 Oct | 2 |
14 | 12846751 | Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes. | 2003 Aug | 1 |